Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 6
2003 3
2004 4
2005 7
2006 8
2007 7
2008 4
2009 8
2010 5
2011 10
2012 5
2013 7
2014 8
2015 7
2016 5
2017 4
2018 7
2019 7
2020 10
2021 25
2022 19
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.
Yan J, Bangalore CR, Nikouyan N, Appelberg S, Silva DN, Yao H, Pasetto A, Weber F, Weber S, Larsson O, Höglund U, Bogdanovic G, Grabbe M, Aleman S, Szekely L, Szakos A, Tuvesson O, Gidlund EK, Cadossi M, Salati S, Tegel H, Hober S, Frelin L, Mirazimi A, Ahlén G, Sällberg M. Yan J, et al. Among authors: hober s. Mol Ther. 2024 Feb 7;32(2):540-555. doi: 10.1016/j.ymthe.2024.01.007. Epub 2024 Jan 11. Mol Ther. 2024. PMID: 38213030 Free article.
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden.
Marking U, Bladh O, Aguilera K, Yang Y, Greilert Norin N, Blom K, Hober S, Klingström J, Havervall S, Åberg M, Sheward DJ, Thålin C. Marking U, et al. Among authors: hober s. Lancet Infect Dis. 2024 Feb;24(2):e80-e81. doi: 10.1016/S1473-3099(23)00779-X. Epub 2024 Jan 5. Lancet Infect Dis. 2024. PMID: 38190833 No abstract available.
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose.
Bladh O, Marking U, Havervall S, Norin NG, Aguilera K, Hober S, Smed-Sörensen A, Gordon M, Blom K, Åberg M, Klingström J, Thålin C. Bladh O, et al. Among authors: hober s. Lancet Microbe. 2023 Jul;4(7):e488. doi: 10.1016/S2666-5247(23)00102-7. Epub 2023 Apr 20. Lancet Microbe. 2023. PMID: 37086736 Free PMC article. No abstract available.
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers.
Marking U, Havervall S, Norin NG, Bladh O, Christ W, Gordon M, Ng H, Blom K, Phillipson M, Mangsbo S, Alm JJ, Smed-Sörensen A, Nilsson P, Hober S, Åberg M, Klingström J, Thålin C. Marking U, et al. Among authors: hober s. Nat Commun. 2023 Mar 22;14(1):1577. doi: 10.1038/s41467-023-36984-1. Nat Commun. 2023. PMID: 36949041 Free PMC article.
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection.
Marking U, Bladh O, Havervall S, Svensson J, Greilert-Norin N, Aguilera K, Kihlgren M, Salomonsson AC, Månsson M, Gallini R, Kriegholm C, Bacchus P, Hober S, Gordon M, Blom K, Smed-Sörensen A, Åberg M, Klingström J, Thålin C. Marking U, et al. Among authors: hober s. Lancet Infect Dis. 2023 Feb;23(2):150-152. doi: 10.1016/S1473-3099(22)00834-9. Epub 2023 Jan 11. Lancet Infect Dis. 2023. PMID: 36640796 Free PMC article. No abstract available.
158 results